Risks and Benefits of Smallpox Vaccination
Author Information
Author(s): Martin I. Meltzer
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
What are the risks and benefits of pre- and postexposure smallpox vaccination?
Conclusion
Most people in the general population would not accept preexposure smallpox vaccination due to the higher risk of vaccine-related adverse events compared to the risk of smallpox.
Supporting Evidence
- Even at a 1-in-10 risk of 1,000 initial smallpox cases, the risk for serious vaccine-related adverse events is greater than the risk for smallpox.
- Healthcare workers would accept preexposure vaccination only if the risk for contact with an infectious case is greater than 1 in 100.
- A telephone survey found that 61% of respondents would accept smallpox vaccination if offered as a precaution against terrorist attacks.
- The model can be applied to other situations involving pre- and postexposure prophylaxis for infectious diseases.
Takeaway
This study looks at whether people should get vaccinated against smallpox before or after being exposed to it, and it finds that many people would say no because the vaccine can cause serious problems.
Methodology
A risk-benefit model was constructed using a standard computer-based spreadsheet to evaluate the risks of smallpox disease against vaccine-related adverse events.
Potential Biases
The model may underestimate the risk for vaccine-related adverse events, biasing the results toward acceptance of vaccination.
Limitations
The model does not consider the need for revaccinations over time and does not account for the actual risk faced by individuals.
Participant Demographics
The study considers individuals from the general population, healthcare workers, and members of investigation teams.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website